Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
AZD6482
i
Other names:
AZD6482
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
AstraZeneca, Wuhan University
Drug class:
PI3Kβ inhibitor
Related drugs:
‹
GSK2636771 (8)
AZD8186 (4)
TGX-221 (1)
CVL237 (0)
GS-9820 (0)
GSK2636771 (8)
AZD8186 (4)
TGX-221 (1)
CVL237 (0)
GS-9820 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
PTEN mutation
Endometrial Cancer
PTEN mutation
Endometrial Cancer
AZD6482
Resistant: D – Preclinical
AZD6482
Resistant
:
D
AZD6482
Resistant: D – Preclinical
AZD6482
Resistant
:
D
PTEN mutation
Endometrial Cancer
PTEN mutation
Endometrial Cancer
A66 + AZD6482
Sensitive: D – Preclinical
A66 + AZD6482
Sensitive
:
D
A66 + AZD6482
Sensitive: D – Preclinical
A66 + AZD6482
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login